학술논문
Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection.
Document Type
Article
Source
Personalized Medicine (17410541); Mar2020, Vol. 17 Issue 2, p83-87, 5p
Subject
Language
ISSN
17410541
Abstract
Copyright of Personalized Medicine (17410541) is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)